NDC 0078-0778

NEVANAC

Nepafenac

NEVANAC is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Nepafenac.

• Product ID: 0078-0778_a2909252-c5f1-421f-9073-b7be90b45b51
• NDC: 0078-0778
• Product Type: Human Prescription Drug
• Proprietary Name: NEVANAC
• Generic Name: Nepafenac
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2005-09-06
• Marketing Category: NDA /
• Application Number: NDA021862
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: NEPAFENAC
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-0778-03

3 mL in 1 BOTTLE (0078-0778-03)

• Marketing Start Date: 2022-07-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "NEVANAC" or generic name "Nepafenac"

NDC	Brand Name	Generic Name
0065-0002	NEVANAC	nepafenac
0078-0778	NEVANAC	nepafenac
0065-1750	ILEVRO	nepafenac
0078-0743	ILEVRO	nepafenac